What is the EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The EV/EBITDA ratio for ENTA stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The estimated TTM average EV/EBITDA ratio for ENTA stock is 37.95x.

What is the estimated 3Y average EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The estimated 3Y average EV/EBITDA ratio for ENTA stock is 28.95x.

What is the estimated 5Y average EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?

The estimated 5Y average EV/EBITDA ratio for ENTA stock is 20.02x.

Enanta Pharmaceuticals (ENTA) EV/EBITDA: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T17:02:07.452Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:02:07.452Z.

Quote observation: 2026-10-06T17:00:46.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 355,338,056
Total debt · period ending 2026-06-30: 55,656,000
Cash · period ending 2026-06-30: 33,419,000
TTM operating EBITDA · period ending 2026-06-30: -53,819,000

FMP input reference: 86fff216fe9f4e43fb815e843488a8aee31e33e8cf855d0ea3412f6f5fc7b913

EV/Sales|P/E Ratio|EBITDA|All Metrics

ENTA EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

37.95x

EV/EBITDA RATIO AVG 3Y

28.95x

EV/EBITDA RATIO AVG 5Y

20.02x

EV/EBITDA RATIO AVG 10Y

N/A

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

ENTA Competitors' EV/EBITDA Ratio

ENTA

Enanta Pharmaceuticals, Inc.

Current

Market Cap

$355.34M

EV/EBITDA Ratio

N/A

TTM Avg

37.95x

3Y Avg

28.95x

5Y Avg

20.02x

ARTV

Artiva Biotherapeutics, Inc.

vs ENTA

Market Cap

$354.47M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FENC

Fennec Pharmaceuticals Inc.

vs ENTA

Market Cap

$356.75M

EV/EBITDA Ratio

N/A

TTM Avg

40.38x

3Y Avg

40.38x

5Y Avg

40.38x

OBIO

Orchestra BioMed Holdings, Inc.

vs ENTA

Market Cap

$349.70M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RLMD

Relmada Therapeutics, Inc.

vs ENTA

Market Cap

$349.28M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EMBC

Embecta Corp.

vs ENTA

Market Cap

$361.92M

EV/EBITDA Ratio

5.40x

TTM Avg

4.73x

3Y Avg

7.57x

5Y Avg

7.31x

IRD

Opus Genetics, Inc.

vs ENTA

Market Cap

$362.46M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OCGN

Ocugen, Inc.

vs ENTA

Market Cap

$362.81M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGC

Canopy Growth Corporation

vs ENTA

Market Cap

$374.11M

EV/EBITDA Ratio

N/A

TTM Avg

682.46x

3Y Avg

682.46x

5Y Avg

682.46x

ARCT

Arcturus Therapeutics Holdings Inc.

vs ENTA

Market Cap

$380.78M

EV/EBITDA Ratio

N/A

TTM Avg

10.71x

3Y Avg

10.71x

5Y Avg

10.71x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Enanta Pharmaceuticals, Inc. (ENTA)	$355.34M	N/A	37.95x	28.95x	20.02x
Artiva Biotherapeutics, Inc. (ARTV)vs ›	$354.47M	N/A	N/A	N/A	N/A
Fennec Pharmaceuticals Inc. (FENC)vs ›	$356.75M	N/A	40.38x	40.38x	40.38x
Orchestra BioMed Holdings, Inc. (OBIO)vs ›	$349.70M	N/A	N/A	N/A	N/A
Relmada Therapeutics, Inc. (RLMD)vs ›	$349.28M	N/A	N/A	N/A	N/A
Embecta Corp. (EMBC)vs ›	$361.92M	5.40x	4.73x	7.57x	7.31x
Opus Genetics, Inc. (IRD)vs ›	$362.46M	N/A	N/A	N/A	N/A
Ocugen, Inc. (OCGN)vs ›	$362.81M	N/A	N/A	N/A	N/A
Canopy Growth Corporation (CGC)vs ›	$374.11M	N/A	682.46x	682.46x	682.46x
Arcturus Therapeutics Holdings Inc. (ARCT)vs ›	$380.78M	N/A	10.71x	10.71x	10.71x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The EV/EBITDA ratio for ENTA stock is N/A.
What is the estimated TTM average EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The estimated TTM average EV/EBITDA ratio for ENTA stock is 37.95x.
What is the estimated 3Y average EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The estimated 3Y average EV/EBITDA ratio for ENTA stock is 28.95x.
What is the estimated 5Y average EV/EBITDA ratio for Enanta Pharmaceuticals, Inc. (ENTA)?: The estimated 5Y average EV/EBITDA ratio for ENTA stock is 20.02x.

ENTA EV/EBITDA Ratio History

DATE	EV/EBITDA RATIO
2020-08-10	60.43x
2020-08-07	59.27x
2020-08-06	58.13x
2020-08-05	57.81x
2020-08-04	59.99x
2020-08-03	59.13x
2020-07-31	57.51x
2020-07-30	59.05x
2020-07-29	58.96x
2020-07-28	60.84x
2020-07-27	63.54x
2020-07-24	60.62x
2020-07-23	61.51x
2020-07-22	62.03x
2020-07-21	62.34x
2020-07-20	66.95x
2020-07-17	67.86x
2020-07-16	66.69x
2020-07-15	67.22x
2020-07-14	65.36x
2020-07-13	63.13x
2020-07-10	64.69x
2020-07-09	64.59x
2020-07-08	63.54x
2020-07-07	63.72x
2020-07-06	63.78x
2020-07-02	63.02x
2020-07-01	64.79x
2020-06-30	63.39x
2020-06-29	61.81x
2020-06-26	62.67x
2020-06-25	64.32x
2020-06-24	63.74x
2020-06-23	64.90x
2020-06-22	63.75x
2020-06-19	61.97x
2020-06-18	62.32x
2020-06-17	63.40x
2020-06-16	64.84x
2020-06-15	63.16x
2020-06-12	61.11x
2020-06-11	60.73x
2020-06-10	64.69x
2020-06-09	66.04x
2020-06-08	65.50x
2020-06-05	64.07x
2020-06-04	63.20x
2020-06-03	64.38x
2020-06-02	63.66x
2020-06-01	64.01x
2020-05-29	65.11x
2020-05-28	65.26x
2020-05-27	64.06x
2020-05-26	69.75x
2020-05-22	70.25x
2020-05-21	69.84x
2020-05-20	71.31x
2020-05-19	69.02x
2020-05-18	73.32x
2020-05-15	70.11x
2020-05-14	68.07x
2020-05-13	68.70x
2020-05-12	67.88x
2020-05-11	42.07x
2020-05-08	41.71x
2020-05-07	41.05x
2020-05-06	41.87x
2020-05-05	41.30x
2020-05-04	41.41x
2020-05-01	38.42x
2020-04-30	37.50x
2020-04-29	39.70x
2020-04-28	40.54x
2020-04-27	43.93x
2020-04-24	43.46x
2020-04-23	42.58x
2020-04-22	43.57x
2020-04-21	43.09x
2020-04-20	44.96x
2020-04-17	44.62x
2020-04-16	43.70x
2020-04-15	42.65x
2020-04-14	43.70x
2020-04-13	42.78x
2020-04-09	43.00x
2020-04-08	42.28x
2020-04-07	41.25x
2020-04-06	41.13x
2020-04-03	41.08x
2020-04-02	40.48x
2020-04-01	40.77x
2020-03-31	41.67x
2020-03-30	41.06x
2020-03-27	38.05x
2020-03-26	40.26x
2020-03-25	37.72x
2020-03-24	38.26x
2020-03-23	37.14x
2020-03-20	37.83x
2020-03-19	37.91x
2020-03-18	32.44x
2020-03-17	35.50x
2020-03-16	33.07x
2020-03-13	43.73x
2020-03-12	39.99x
2020-03-11	42.90x
2020-03-10	43.14x
2020-03-09	41.47x
2020-03-06	44.22x
2020-03-05	45.02x
2020-03-04	44.51x
2020-03-03	42.39x
2020-03-02	42.95x
2020-02-28	41.22x
2020-02-27	40.34x
2020-02-26	41.35x
2020-02-25	41.20x
2020-02-24	41.67x
2020-02-21	43.13x
2020-02-20	43.23x
2020-02-19	43.25x
2020-02-18	43.51x
2020-02-14	42.05x
2020-02-13	42.53x
2020-02-12	42.80x
2020-02-11	42.81x
2020-02-10	27.81x
2020-02-07	27.84x
2020-02-06	27.76x
2020-02-05	27.86x
2020-02-04	27.06x
2020-02-03	26.29x
2020-01-31	25.63x
2020-01-30	26.16x
2020-01-29	26.27x
2020-01-28	27.01x
2020-01-27	26.57x
2020-01-24	27.35x
2020-01-23	27.95x
2020-01-22	28.46x
2020-01-21	28.98x
2020-01-17	28.97x
2020-01-16	29.30x
2020-01-15	29.50x
2020-01-14	29.36x
2020-01-13	28.86x
2020-01-10	29.43x
2020-01-09	30.21x
2020-01-08	30.48x
2020-01-07	30.52x
2020-01-06	31.07x
2020-01-03	30.86x
2020-01-02	31.09x
2019-12-31	30.97x
2019-12-30	30.85x
2019-12-27	31.35x
2019-12-26	31.89x
2019-12-24	32.90x
2019-12-23	32.42x
2019-12-20	32.10x
2019-12-19	32.07x
2019-12-18	32.15x
2019-12-17	32.00x
2019-12-16	32.07x
2019-12-13	33.49x
2019-12-12	33.00x
2019-12-11	32.26x
2019-12-10	32.48x
2019-12-09	31.98x
2019-12-06	32.17x
2019-12-05	31.60x
2019-12-04	31.50x
2019-12-03	31.84x
2019-12-02	31.11x
2019-11-29	31.95x
2019-11-27	18.36x
2019-11-26	18.09x
2019-11-25	18.13x
2019-11-22	17.52x
2019-11-21	18.39x
2019-11-20	17.87x
2019-11-19	18.19x
2019-11-18	18.34x
2019-11-15	18.10x
2019-11-14	17.93x
2019-11-13	17.92x
2019-11-12	17.78x
2019-11-11	17.85x
2019-11-08	18.39x
2019-11-07	17.79x
2019-11-06	17.80x
2019-11-05	18.10x
2019-11-04	17.71x
2019-11-01	17.47x
2019-10-31	17.57x
2019-10-30	17.64x
2019-10-29	17.35x
2019-10-28	17.44x
2019-10-25	17.20x
2019-10-24	17.15x
2019-10-23	17.38x
2019-10-22	17.52x
2019-10-21	17.60x
2019-10-18	17.20x
2019-10-17	17.56x
2019-10-16	17.11x
2019-10-15	17.13x
2019-10-14	16.75x
2019-10-11	16.99x
2019-10-10	16.76x
2019-10-09	16.66x
2019-10-08	16.70x
2019-10-07	17.33x
2019-10-04	17.40x
2019-10-03	18.08x
2019-10-02	18.31x
2019-10-01	17.76x
2019-09-30	17.32x
2019-09-27	17.38x
2019-09-26	17.45x
2019-09-25	20.81x
2019-09-24	20.97x
2019-09-23	21.00x
2019-09-20	20.95x
2019-09-19	20.72x
2019-09-18	20.63x
2019-09-17	20.09x
2019-09-16	20.37x
2019-09-13	19.78x
2019-09-12	20.22x
2019-09-11	20.38x
2019-09-10	19.69x
2019-09-09	19.04x
2019-09-06	19.49x
2019-09-05	20.02x
2019-09-04	20.15x
2019-09-03	19.77x
2019-08-30	20.58x
2019-08-29	20.82x
2019-08-28	20.64x
2019-08-27	20.35x
2019-08-26	20.63x
2019-08-23	20.38x
2019-08-22	20.64x
2019-08-21	21.34x
2019-08-20	21.14x
2019-08-19	21.09x
2019-08-16	21.01x
2019-08-15	20.51x
2019-08-14	20.92x
2019-08-13	21.39x
2019-08-12	20.66x
2019-08-09	16.66x
2019-08-08	16.56x
2019-08-07	16.43x
2019-08-06	16.05x
2019-08-05	15.43x
2019-08-02	16.28x
2019-08-01	16.93x
2019-07-31	17.07x

Showing the most recent 260 of 1,526 data points. The chart above shows the full history.

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics

EV/EBITDA Ratio: N/A

ENTA EV/EBITDA Ratio Chart

ENTA Average EV/EBITDA Ratio Chart

ENTA EV/EBITDA Ratio Metrics

ENTA Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

ENTA EV/EBITDA Ratio History

Related Metrics